Miras, Alecia Faith R.

HRN: 20-55-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/30/2023
05/06/2023
PO
1ml
QID
T/c Hand Foot Mouth Disease
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Eye, Ear, Nose, Throat, & MouthProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: